A new family of guanidinium-rich molecular transporters featuring a novel oligocarbonate backbone with 1,7-side chain spacing is described. Conjugates can be rapidly assembled irrespective of length in a one-step oligomerization strategy that can proceed with concomitant introduction of probes (or by analogy drugs). The new transporters exhibit excellent cellular entry as determined by flow cytometry and fluorescence microscopy, and the functionality of their drug delivery capabilities was confirmed by the delivery of the bioluminescent small molecule probe luciferin and turnover by its intracellular target enzyme
Abstract This report highlights the importance of hydrophobic groups mimicking the side chains of ar...
There is mounting interest in developing antisense and siRNA oligonucleotides into therapeutic entit...
Addressing intracellular targets is a challenging task that requires potent molecular transporters c...
The polyanionic nature of oligonucleotides and their enzymatic degradation present challenges for th...
The design, synthesis, and biological evaluation of a new family of highly effective cell-penetratin...
A highly versatile and step-economical route to a new class of guanidinium-rich molecular transporte...
Inspired originally by peptides that traverse biological barriers, research on molecular transporter...
High molecular weight and highly-charged biomolecules are emerging as drugs with high selectivity an...
The cellular uptake of biologically relevant cargos is a longstanding challenge in drug discovery pr...
A novel unconventional supramolecular oligo-cationic structure (Agm6-M-PEG-OCH3) has been synthesize...
Controlled translocation of molecules and ions across lipid membranes is the basis of numerous biolo...
A novel unconventional supramolecular oligo-cationic structure (Agm6-M-PEG-OCH3) has been synthesize...
Nature frequently uses guanidinium group (mainly found in the amino acid arginine) to bind via ion p...
A novel unconventional supramolecular oligo-cationic structure (Agm-M-PEG-OCH) has been synthesized ...
The therapeutic use of antisense and siRNA oligonucleotides has been constrained by the limited abil...
Abstract This report highlights the importance of hydrophobic groups mimicking the side chains of ar...
There is mounting interest in developing antisense and siRNA oligonucleotides into therapeutic entit...
Addressing intracellular targets is a challenging task that requires potent molecular transporters c...
The polyanionic nature of oligonucleotides and their enzymatic degradation present challenges for th...
The design, synthesis, and biological evaluation of a new family of highly effective cell-penetratin...
A highly versatile and step-economical route to a new class of guanidinium-rich molecular transporte...
Inspired originally by peptides that traverse biological barriers, research on molecular transporter...
High molecular weight and highly-charged biomolecules are emerging as drugs with high selectivity an...
The cellular uptake of biologically relevant cargos is a longstanding challenge in drug discovery pr...
A novel unconventional supramolecular oligo-cationic structure (Agm6-M-PEG-OCH3) has been synthesize...
Controlled translocation of molecules and ions across lipid membranes is the basis of numerous biolo...
A novel unconventional supramolecular oligo-cationic structure (Agm6-M-PEG-OCH3) has been synthesize...
Nature frequently uses guanidinium group (mainly found in the amino acid arginine) to bind via ion p...
A novel unconventional supramolecular oligo-cationic structure (Agm-M-PEG-OCH) has been synthesized ...
The therapeutic use of antisense and siRNA oligonucleotides has been constrained by the limited abil...
Abstract This report highlights the importance of hydrophobic groups mimicking the side chains of ar...
There is mounting interest in developing antisense and siRNA oligonucleotides into therapeutic entit...
Addressing intracellular targets is a challenging task that requires potent molecular transporters c...